Melola Discovery

← Melola Discovery

Akses terbuka Jurnal

Dealing with A State of Emergency: A Comparative Study Between Indonesia and Malaysia in Government Use for Pharmaceutical Products

International Law Discourse in Southeast Asia · Vol. 4 No. 2 (2025) · hlm. 77–112

DOI
10.15294/ildisea.v5i2.29671
ISSN
2829-9655, 2830-0297
Terbit
2025-12-12
Penerbit
Universitas Negeri Semarang
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

The implementation of patents by the government has become a national policy to control the spread of COVID-19 by helping drug supplies in emergencies and urgent situations. The purpose of this research is to analyse patent regulation by the government (Government Use) for pharmaceutical products in the state of emergency in Indonesia by comparing with Government Use in Malaysia. This research is legal research using secondary data with qualitative analysis. The implementation of patents by the government on the Covid-19 drugs remdesivir and favipiravir, whose application in Indonesia has been based on the provisions regulated by TRIPS and the DOHA Declaration. The implementation of this policy is due to a very urgent need in efforts to tackle the COVID-19 pandemic. Malaysia has also implemented the same policy to address the need to import a generic version of the Hepatitis C drug. It is hoped that the implementation of patents by the Government on the drugs remdesivir and favipiravir can facilitate access for Covid-19 patients who need them and can be an effective strategy to deal with the Covid-19 outbreak.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 100 tautan kepenulisan bersama · 1 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • State University of Semarang
  • Direktorat Jenderal Imigrasi
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Martitah MartitahAfiliasi tidak diketahui11
Pujiono PujionoAfiliasi tidak diketahui9
Yuli Prasetyo AdhiAfiliasi tidak diketahui9
Rini FidiyaniAfiliasi tidak diketahui4
MUHAMMAD SHIDQON PRABOWOAfiliasi tidak diketahui3
Mohammad Reza FachruddinAfiliasi tidak diketahui3
Rahmawati Mohd. YusoffAfiliasi tidak diketahui3
Andry SetiawanAfiliasi tidak diketahui2
Ivan Bhakti YudistiraAfiliasi tidak diketahui2
LAGA SUGIARTOAfiliasi tidak diketahui2
Jafar SidikAfiliasi tidak diketahui2
Asep RozaliAfiliasi tidak diketahui2
Rodiyah RodiyahAfiliasi tidak diketahui2
Abraham AbrahamAfiliasi tidak diketahui2
Windi AgustinAfiliasi tidak diketahui2
Masyitha Aulia ArifaAfiliasi tidak diketahui2
Saru ArifinAfiliasi tidak diketahui2
Dani MuhtadaAfiliasi tidak diketahui2
I Made Widia Wirya PutraAfiliasi tidak diketahui2
Rahmawati Mohd YusoffAfiliasi tidak diketahui2
Slamet SumartoAfiliasi tidak diketahui2
Gianefi SafitriDirektorat Jenderal Imigrasi1
SIGIT EKA PRAMONOAfiliasi tidak diketahui1
NURROHMAH NURROHMAHAfiliasi tidak diketahui1
RATNA WIDYANINGSIHAfiliasi tidak diketahui1
Delia PangestiAfiliasi tidak diketahui1
Muhamad Syahrul ApriliyantoAfiliasi tidak diketahui1
Khasanah S. L.Afiliasi tidak diketahui1
Harry NugrohoAfiliasi tidak diketahui1
Pradita Adila LarasatiAfiliasi tidak diketahui1
Arif HidayatAfiliasi tidak diketahui1
Hayyu SasviaAfiliasi tidak diketahui1
Indrayana Chandra KarunaAfiliasi tidak diketahui1
R. SuhartoAfiliasi tidak diketahui1
Deni HaspadaAfiliasi tidak diketahui1
Edi PramonoAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://journal.unnes.ac.id/journals/ildisea/oai, pertama di-harvest 5 Nov 2026, terakhir terlihat 5 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Dealing with A State of Emergency: A Comparative Study Between Indonesia and Malaysia in Government Use for Pharmaceutical Products</dc:title>
	<dc:creator xml:lang="en">Sulistianingsih, Dewi</dc:creator>
	<dc:creator xml:lang="en">Prasetyo Adhi, Yuli</dc:creator>
	<dc:creator xml:lang="en">Puji Lestari, Diaj</dc:creator>
	<dc:creator xml:lang="en">Binti Mohd Yusoff, Rahmawati</dc:creator>
	<dc:subject xml:lang="en">Government Patent Implementation</dc:subject>
	<dc:subject xml:lang="en">Covid-19</dc:subject>
	<dc:subject xml:lang="en">Remdesivir</dc:subject>
	<dc:subject xml:lang="en">Favipiravir</dc:subject>
	<dc:description xml:lang="en">The implementation of patents by the government has become a national policy to control the spread of COVID-19 by helping drug supplies in emergencies and urgent situations. The purpose of this research is to analyse patent regulation by the government (Government Use) for pharmaceutical products in the state of emergency in Indonesia by comparing with Government Use in Malaysia. This research is legal research using secondary data with qualitative analysis. The implementation of patents by the government on the Covid-19 drugs remdesivir and favipiravir, whose application in Indonesia has been based on the provisions regulated by TRIPS and the DOHA Declaration. The implementation of this policy is due to a very urgent need in efforts to tackle the COVID-19 pandemic. Malaysia has also implemented the same policy to address the need to import a generic version of the Hepatitis C drug. It is hoped that the implementation of patents by the Government on the drugs remdesivir and favipiravir can facilitate access for Covid-19 patients who need them and can be an effective strategy to deal with the Covid-19 outbreak.</dc:description>
	<dc:publisher xml:lang="en">Universitas Negeri Semarang</dc:publisher>
	<dc:date>2025-12-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unnes.ac.id/journals/ildisea/article/view/29671</dc:identifier>
	<dc:identifier>10.15294/ildisea.v5i2.29671</dc:identifier>
	<dc:source xml:lang="en">International Law Discourse in Southeast Asia; Vol. 4 No. 2 (2025): July-December, 2025; 77-112</dc:source>
	<dc:source>2829-9655</dc:source>
	<dc:source>2830-0297</dc:source>
	<dc:source>10.15294/ildisea.v4i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.unnes.ac.id/journals/ildisea/article/view/29671/7558</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Dewi Sulistianingsih, Yuli Prasetyo Adhi, Diah Puji Lestari, Rahmawati Binti Mohd Yusoff (Author)</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>